Bacterial Vaginosis and Correlates in Women of Reproductive Age in Thika, Kenya


Background: Bacterial vaginosis (BV) is the most common cause of abnormal vaginal discharge among women of childbearing age which is associated with STI/HIV and adverse birth outcomes. The Main objective of this study was to determine the prevalence and correlates of BV among women of reproductive age in Thika. Methods: Between July 2010 and February 2011, 193 women of reproductive age (18 - 49 years) were enrolled from family planning and ante-natal clinics in Thika District Hospital, Kenya. The study was descriptive cross sectional in which organisms were identified from vaginal specimens using culture, biochemical testing and Nugent score method. Statistical analyses included conventional descriptive statistics and multivariable analysis using regression. Results: Of one hundred and ninety three specimens, 9.3% were Mobiluncus isolates, 23.0% Bacteriodes species and 67.7% Gardnerella vaginalis. Among the study participants, 77.7% had non-classical BV with a score of 7 - 8 while 22.3% classical BV with a score of 9 - 10 indicating complete depletion of Lactobacillus species. Whiff test was positive for 89.1% (74) of the 83 patients with BV. Though, 32.5% of women with BV had a vaginal pH of more than 4.5, only 66.0% of women fulfilling the criteria of BV had a characteristic discharge. Conclusions: In this population, the prevalence of BV was relatively high when compared with other community settings. BV was associated with condom use and multiple sexual partners. Further research is needed to understand their role in BV and the socioeconomic context surrounding the condition in Kenya.

Share and Cite:

J. Nzomo, P. Waiyaki and R. Waihenya, "Bacterial Vaginosis and Correlates in Women of Reproductive Age in Thika, Kenya," Advances in Microbiology, Vol. 3 No. 3, 2013, pp. 249-254. doi: 10.4236/aim.2013.33036.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] R. Amsel, A. Totten, D. Eschenbach and K. Holmes, “Non-Specific Vaginitis, Diagnostic Criteria Microbial and Epidemiologic Associations,” American Journal of Medicine, Vol. 74, No. 1, 1983, pp. 14-22. doi:10.1016/0002-9343(83)91112-9
[2] J. Atashili, M. Ndumbe and J. Smith, “Bacterial Vaginosis and HIV Acquisition: A Meta-Analysis of Published Studies,” Journal of Infectious Diseases, Vol. 22, No. 12, 2008, pp. 1493-1501.
[3] E. Allworth and F. Peipert, “Prevalence of Bacterial Vaginosis: 2001-2004 National Health and Nutrition Examination Survey Data,” Obstetrics & Gynecology, Vol. 109, No. 1, 2007, pp. 114-120. doi:10.1097/01.AOG.0000247627.84791.91
[4] M. Brotman, M. Klebanoff and R. Nansel, “Bacterial Vaginosis Assessed by Gram Stain and Diminished Colonization Resistance to Incident Gonococcal, Chlamydial, and Trichomonal Genital Infection,” Journal of Infectious Diseases, Vol. 202, No. 12, 2010, pp. 1907-1915. doi:10.1086/657320
[5] E. Bukusi, R. Cohen, S. Meier, G. Waiyaki, R. Nguti, N. Njeri and K. Holmes, “Bacterial Vaginosis: Risk Factors among Kenyan Women and Their Male Partners,” Sexually Transmitted Disease, Vol. 33, 2006, pp. 361-367.
[6] J. Christopher and V. Snehalata, “Syndromic Management of Vaginal Discharge among Women in a Reproductive Health Clinic in India,” Sexually Transmitted Disease, Vol. 76, 2000, pp. 303-306.
[7] O. Fernández-Limia, C. Villar and R. Faure, “Prevalence of Trichomoniasis, Bacterial Vaginosis and Candidiasis in Women Attending Sexual Transmitted Infections and Gynecologic Clinic Using an Immunologic Latex Agglutination Test,” American Journal of Obstetrics & Gynecology, Vol. 166, 2007, pp. 938-934.
[8] N. Fredricks, L. Fiedler and M. Marrazzo, “Molecular Identification of Bacteria Associated with Bacterial Vaginosis,” The New England Journal of Medicine, Vol. 353, No. 18, 2005, pp. 1899-1911. doi:10.1056/NEJMoa043802
[9] P. Nugent, A. Krohn and L. Hillier, “Reliability of Diagnosing Bacterial Vaginosis is Improved by a Standardized Method of Gram Stain Interpretation,” Journal of Clinical Microbiology, Vol. 29, No. 2, 1991, pp. 297-301.
[11] K. Fonck, N. Kidula, N. Temmerman and W. Jaoko, B. Estimable and P. Claeys, “Sexually Transmitted Infections and Pelvic Inflammatory Disease,” American Journal of Epidemiology, Vol. 162, 2000, pp. 585-590.
[12] H. Koumans, M. Sternberg and C. Bruce, “The Prevalence of Bacterial Vaginosis in the United States, 2001-2004; Associations with Symptoms, Sexual Behaviors, and Reproductive Health,” Sexually Transmitted Disease, Vol. 34, 2007, pp. 864-869.
[13] E. H. Koumans, L. E. Markowitz, V. Hogan and CDC BV Working Group, “Indications for Therapy and Treatment Recommendations for Bacterial Vaginosis in Non Pregnant and Pregnant Women: A Synthesis of Data,” Clinical Infectious Diseases, Vol. 35, No. 2, 2002, pp. 152-172. doi:10.1086/342103
[14] J. Bornstein and H. Abramovici, “The Classis Approach to Diagnosis of Vulvo-Vaginitis: A Critical Analysis,” Infect Disease in Obstetrics and Gynecology, Vol. 164, No. 2, 2001, pp. 105-111. doi:10.1155/S1064744901000187
[15] L. Gardner and D. Dukes, “Haemophilus vaginalis vaginitis: A Newly Defined Specific Infection Previously Classified Non-Specific Vaginitis,” American Journal of Obstetrics and Gynecology, Vol. 69, 1955, pp. 962-976.
[16] F. Lamont, J. Sobel and A. Akins, “The Vaginal Microbiome: New Information about Genital Tract Flora Using Molecular Based Techniques,” BJOG, Vol. 118, No. 5, 2011, pp. 533-549. doi:10.1111/j.1471-0528.2010.02840.x
[17] S. Lofmark, C. Edlund and E. Nord, “Metronidazole Is Still the Drug of Choice for Treatment of Anaerobic Infections,” Clinical Infectious Diseases, Vol. 50, No. 1, 2010, pp. S16-S23. doi:10.1086/647939
[18] P. Menard, F. Fenollar, M. Henry, F. Bretelle and D. Raoult, “Molecular Quantification of Gardnerella vaginalis and Atopobium vaginae Loads to Predict Bacterial Vaginosis,” Clinical Infectious Diseases, Vol. 47, No. 1, 2008, pp. 33-43. doi:10.1086/588661
[19] H. Mikamo, K. Kawazoe, K. Izumi, K. Watanabe, K. Ueno and T. Tamaya, “Comparative Study on Vaginal or Oral Treatment of Bacterial Vaginosis,” Chemotherapy, Vol. 43, No. 1, 1997, pp. 60-68. doi:10.1159/000239537
[20] J. Sobel, F. Peipert and J. McGregor, “Efficacy of Clindamycin Vaginal Ovule (3-Day Treatment) vs Clindamycin Vaginal Cream (7-Day Treatment) in Bacterial Vaginosis,” Infectious Diseases in Obstetrics and Gynecology, Vol. 9, No. 1, 2001, pp. 9-15. doi:10.1155/S1064744901000035
[21] E. Calzolari, R. Masciangelo and V. Milite, “Bacterial Vaginosis and Contraceptive Methods,” American Journal of Obstetrics and Gynecology, Vol. 70, No. 3, 2000, pp 341-346.
[22] R. Cohen, P. Garcia and K. Nelson, “Bacterial Vaginosis and HIV Seroprevalence among Female Commercial Sex Workers in Chiang Mai, Thailand,” American Journal of Obstetrics and Gynecology, Vol. 9, 1992, pp. 1093-1097.
[23] P. Hay, N. Ugwumadu and T. Manyonda, “Oral Clindamycin Prevents Spontaneous Preterm Birth and Mid Trimester Miscarriage in Pregnant Women with Bacterial Vaginosis,” The International Journal of STD & AIDS, Vol. 12, No. 2, 2001, pp. 70-71.
[24] C. Miller, H. Swygard and M. Hobbs, “The Prevalence of Trichomoniasis in Young Adults in the United States,” Sexually Transmitted Disease, Vol. 32, 2005, pp. 593-598.

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.